Laparoscopic Cholecystectomy is no More Risky in Emergent Cases With in Cardiopulmonary Risk: Fundus-Callot Cholecystectomy With Low Pressure Pneumo-peritoneum VS Open Cholecystectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04373447 |
Recruitment Status :
Completed
First Posted : May 4, 2020
Last Update Posted : May 4, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Introduction:
In the last decades and due to improvement of medical heath care, large number of elderly persons were prevalence. Old age usually had cardiopulmonary different diseases. Biliary problems are high in old age. advancement of laparoscopic that occurred in the last years made the use of laparoscopy is available in these cardiopulmonary risk patients. many studies faced the role of laparoscopy in acute cholecystitis in elderly but no studies stated a new and a safe laparoscopic approach to the patients.
Aim: compare between Fundus-Calot cholecystectomy with low pressure pneumo-peritoneum VS open cholecystectomy in Emergency cases with cardiopulmonary risk patients as regard intraoperative data and postoperative complications.
Patients and methods:
This study prospective randomized controlled study was conducted on 374 cases with acute cholecystitis, biliary colic, mucocele and pyocele of gall bladder in emergency general surgery department. Patients were divided into 2 groups, Group A: fundus-Calot approach (235cases) and Group B (235cases): classical open approach
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Laparoscopy | Procedure: lap fundus-calot cholecystectomy Procedure: open cholecystectomy | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 2 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Laparoscopic Cholecystectomy is no More Risky in Emergent Cases With in Cardiopulmonary Risk: Fundus-Callot Cholecystectomy With Low Pressure Pneumo-peritoneum VS Open Cholecystectomy - Randomized Controlled Trials |
Actual Study Start Date : | January 1, 2015 |
Actual Primary Completion Date : | January 1, 2018 |
Actual Study Completion Date : | January 1, 2020 |
Arm | Intervention/treatment |
---|---|
Active Comparator: fundus-calot laparoscopic cholecystectomy
use laparoscopic fundus first then calot dissection cholecystectomy
|
Procedure: lap fundus-calot cholecystectomy
use laparoscopic fundus-calot approach |
Active Comparator: open cholecystectomy
open cholecystectomy
|
Procedure: open cholecystectomy
use open approach |
- duration of operation [ Time Frame: 2 hours ]in minutes

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age: any age.
- Sex: Male and Non pregnant female.
- Patients with cardiopulmonary diseases.
- Patients who diagnose acute cholecystitis not improving on medical treatment for 48 hours.
- Patients with biliary colic, mucocele of gall bladder and pyocele of gall bladder.
- American Society of Anesthesiologist's (ASA) score: grade I, II, III.
Exclusion Criteria:
- ASA grade IV
- Patients refuse surgery.
- Documented neurological, renal and Liver disease.
- Previous percutaneous cholecystostomy
- Cases not tolerated CO2 insufflation from the start.
- Other associated problems as acute cholangitis, pancreatitis, gastro-intestinal cancer or bile duct diseases

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04373447
Egypt | |
Tamer Alsaied Alnaimy | |
Zagazig, Sharkia, Egypt, 055 | |
Tamer Alsaied Alnaimy | |
Zagazig, Sharkia, Egypt, 1234 |
Responsible Party: | Tamer Alsaied Alnaimy, assistant professour, Zagazig University |
ClinicalTrials.gov Identifier: | NCT04373447 |
Other Study ID Numbers: |
lap cholecystectomy 2 |
First Posted: | May 4, 2020 Key Record Dates |
Last Update Posted: | May 4, 2020 |
Last Verified: | April 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Pneumoperitoneum Peritoneal Diseases Digestive System Diseases |